A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...
Vous n'êtes pas connecté
A new study has found that an anti-obesity drug called tirzepatide, which is sold under the names Mounjaro for diabetes and Zepbound for obesity, may help slow down the growth of breast cancer linked to obesity. The research was presented at ENDO 2025, the annual meeting of the Endocrine Society held in San Francisco, California. […] The post New obesity drug could slow down breast cancer growth appeared first on Knowridge Science Report.
A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...
A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth...
Cancer deaths linked to obesity have tripled in the United States over the last 20 years, according to new research presented at ENDO 2025, the annual...
Cancer deaths linked to obesity have tripled in the United States over the last 20 years, according to new research presented at ENDO 2025, the annual...
New research suggests that eating less just two days a week could be more helpful than other popular diet plans for people with obesity and type 2...
New research suggests that eating less just two days a week could be more helpful than other popular diet plans for people with obesity and type 2...
In a new mouse-model study presented at bENDO 2025/b, the researchers observed that tirzepatide, a drug that is approved to treat type 2 diabetes
A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, but eating more protein...
A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, but eating more protein...